Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.081 USD | 0.00% | -5.59% | +4.79% |
26/06 | HealthLynked Corp. Promotes Bill Crupi to Chief Operating Officer | CI |
03/06 | HealthLynked Corp. announced that it has received $1 million in funding | CI |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 11.5 | 14.91 | 21.18 | 112.4 | 17.47 | 21.32 |
Enterprise Value (EV) 1 | 13.1 | 17.37 | 23.92 | 110.1 | 18.89 | 23.22 |
P/E ratio | -1.84 x | -2.33 x | -2.6 x | -9.45 x | -1.59 x | -20.1 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 5.09 x | 3.71 x | 3.95 x | 16.6 x | 2.98 x | 3.73 x |
EV / Revenue | 5.8 x | 4.32 x | 4.46 x | 16.2 x | 3.23 x | 4.06 x |
EV / EBITDA | -4.44 x | -5.54 x | -8.47 x | -26.1 x | -3.72 x | -6.67 x |
EV / FCF | -25.6 x | 417 x | -50.2 x | -35.7 x | -5.97 x | -18.4 x |
FCF Yield | -3.9% | 0.24% | -1.99% | -2.8% | -16.7% | -5.43% |
Price to Book | -3.92 x | -5.41 x | 15.7 x | 15.6 x | 56.3 x | 26.6 x |
Nbr of stocks (in thousands) | 85,179 | 1,06,513 | 1,87,968 | 2,37,921 | 2,54,989 | 2,75,928 |
Reference price 2 | 0.1350 | 0.1400 | 0.1127 | 0.4724 | 0.0685 | 0.0773 |
Announcement Date | 01/04/19 | 30/03/20 | 31/03/21 | 31/03/22 | 31/03/23 | 01/04/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 2.259 | 4.019 | 5.365 | 6.779 | 5.858 | 5.722 |
EBITDA 1 | -2.948 | -3.136 | -2.824 | -4.216 | -5.084 | -3.48 |
EBIT 1 | -2.972 | -3.209 | -3.072 | -5.043 | -5.914 | -3.832 |
Operating Margin | -131.57% | -79.85% | -57.25% | -74.4% | -100.95% | -66.96% |
Earnings before Tax (EBT) 1 | -5.791 | -5.529 | -5.755 | -10.41 | -8.067 | -3.614 |
Net income 1 | -5.791 | -5.529 | -5.755 | -10.41 | -8.816 | -1.012 |
Net margin | -256.34% | -137.57% | -107.27% | -153.61% | -150.49% | -17.69% |
EPS 2 | -0.0735 | -0.0600 | -0.0434 | -0.0500 | -0.0431 | -0.003850 |
Free Cash Flow 1 | -0.5109 | 0.0417 | -0.4764 | -3.085 | -3.164 | -1.261 |
FCF margin | -22.61% | 1.04% | -8.88% | -45.51% | -54% | -22.04% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 01/04/19 | 30/03/20 | 31/03/21 | 31/03/22 | 31/03/23 | 01/04/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 1.6 | 2.46 | 2.73 | - | 1.43 | 1.9 |
Net Cash position 1 | - | - | - | 2.31 | - | - |
Leverage (Debt/EBITDA) | -0.5433 x | -0.7838 x | -0.9673 x | - | -0.2809 x | -0.5453 x |
Free Cash Flow 1 | -0.51 | 0.04 | -0.48 | -3.09 | -3.16 | -1.26 |
ROE (net income / shareholders' equity) | 232% | 191% | 771% | -243% | -215% | -646% |
ROA (Net income/ Total Assets) | -428% | -135% | -36.3% | -33.7% | -48.4% | -54.1% |
Assets 1 | 1.352 | 4.099 | 15.85 | 30.92 | 18.22 | 1.873 |
Book Value Per Share 2 | -0.0300 | -0.0300 | 0.0100 | 0.0300 | 0 | 0 |
Cash Flow per Share 2 | 0 | 0 | 0 | 0.0100 | 0 | 0 |
Capex 1 | 0 | 0.01 | 0.02 | 0.02 | 0.02 | 0 |
Capex / Sales | 0.13% | 0.25% | 0.47% | 0.28% | 0.4% | 0.03% |
Announcement Date | 01/04/19 | 30/03/20 | 31/03/21 | 31/03/22 | 31/03/23 | 01/04/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+4.79% | 22.84M | |
+26.03% | 89.18B | |
-26.41% | 76.11B | |
+1.62% | 27.11B | |
-10.45% | 17.13B | |
-0.14% | 16.83B | |
+0.32% | 15.4B | |
+76.88% | 13.68B | |
+80.32% | 13.25B | |
-25.79% | 12.83B |
- Stock Market
- Equities
- HLYK Stock
- Financials HealthLynked Corp.